ZA200800153B - Inhibitors of soluble adenylate cyclase - Google Patents

Inhibitors of soluble adenylate cyclase

Info

Publication number
ZA200800153B
ZA200800153B ZA200800153A ZA200800153A ZA200800153B ZA 200800153 B ZA200800153 B ZA 200800153B ZA 200800153 A ZA200800153 A ZA 200800153A ZA 200800153 A ZA200800153 A ZA 200800153A ZA 200800153 B ZA200800153 B ZA 200800153B
Authority
ZA
South Africa
Prior art keywords
inhibitors
adenylate cyclase
soluble adenylate
soluble
cyclase
Prior art date
Application number
ZA200800153A
Other languages
English (en)
Inventor
Buchmann Bernd
Fritsch Martin
Boemer Ulf
Nguyen Duy
Menzenbach Bernd
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200800153B publication Critical patent/ZA200800153B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
ZA200800153A 2005-06-08 2008-01-07 Inhibitors of soluble adenylate cyclase ZA200800153B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
ZA200800153B true ZA200800153B (en) 2009-03-25

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800153A ZA200800153B (en) 2005-06-08 2008-01-07 Inhibitors of soluble adenylate cyclase

Country Status (23)

Country Link
EP (1) EP1888058B1 (xx)
JP (1) JP2008542422A (xx)
KR (1) KR20080016617A (xx)
CN (1) CN101193631A (xx)
AR (1) AR054378A1 (xx)
AT (1) ATE431736T1 (xx)
AU (1) AU2006256857A1 (xx)
BR (1) BRPI0610934A2 (xx)
CA (1) CA2606692A1 (xx)
CR (1) CR9578A (xx)
DE (2) DE102005027274A1 (xx)
DO (1) DOP2006000130A (xx)
EA (1) EA200702590A1 (xx)
EC (1) ECSP078024A (xx)
GT (1) GT200600244A (xx)
IL (1) IL186914A0 (xx)
MX (1) MX2007015493A (xx)
NO (1) NO20080104L (xx)
PE (1) PE20061488A1 (xx)
TW (1) TW200716090A (xx)
UY (1) UY29583A1 (xx)
WO (1) WO2006131398A2 (xx)
ZA (1) ZA200800153B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
US20020064849A1 (en) * 2000-09-05 2002-05-30 Herr John C. Human soluble testicular adenylyl cyclase
OA12626A (en) * 2001-06-28 2006-06-13 Pfizer Prod Inc triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP)and/or apolipoprotein B(APO B) secretion.
CN1578663B (zh) * 2001-09-14 2011-05-25 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
EP1663242B1 (en) * 2003-08-07 2011-04-27 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
CA2542096A1 (en) * 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
EP1706114B1 (en) * 2004-01-21 2012-12-26 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
AU2005225471B2 (en) * 2004-03-26 2011-05-12 Methylgene Inc. Inhibitors of histone deacetylase
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
IL186914A0 (en) 2008-02-09
ATE431736T1 (de) 2009-06-15
BRPI0610934A2 (pt) 2010-08-03
NO20080104L (no) 2008-03-03
DOP2006000130A (es) 2006-11-30
GT200600244A (es) 2007-01-23
EP1888058B1 (en) 2009-05-20
AU2006256857A1 (en) 2006-12-14
CA2606692A1 (en) 2006-12-14
PE20061488A1 (es) 2007-02-03
WO2006131398A3 (en) 2007-04-19
EA200702590A1 (ru) 2008-06-30
AR054378A1 (es) 2007-06-20
ECSP078024A (es) 2008-01-23
DE102005027274A1 (de) 2006-12-14
UY29583A1 (es) 2007-01-31
JP2008542422A (ja) 2008-11-27
EP1888058A2 (en) 2008-02-20
TW200716090A (en) 2007-05-01
WO2006131398A2 (en) 2006-12-14
CN101193631A (zh) 2008-06-04
DE602006006908D1 (de) 2009-07-02
KR20080016617A (ko) 2008-02-21
MX2007015493A (es) 2008-02-22
CR9578A (es) 2008-03-06

Similar Documents

Publication Publication Date Title
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
ZA200702394B (en) Indozolone derivatives as 11b-HSD1 inhibitors
HK1119696A1 (en) Pyridopyrimidinone inhibitors of pi3k pi3k
PL2094263T3 (pl) Pochodne 2-adamantylo-butyroamidowe jako selektywne inhibitory 11beta-HSD1
IL222698A0 (en) Benzazole derivatives, compositions, and methods of use as b- secretase inhibitors
IL192580A0 (en) Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
IL198247A0 (en) Indazole derivatives useful as l-cpt1 inhibitors
IL194755A0 (en) Pyrimidine derivatives as pi3k inhibitors
HK1163677A1 (zh) 可用作激酶抑制劑的吡唑基氨基吡啶衍生物
IL197090A (en) A method for the identification of inhibitors of glutaminyl cyclase variants
PL1960352T3 (pl) Pochodne 2-adamantylomocznikowe jako selektywne inhibitory 11BETA-HSD1
IL189048A (en) Uranium derivatives as 3-gsk inhibitors
EP2046333A4 (en) THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE
SI2078001T1 (sl) Derivati diazepan-acetamida kot selektivni zaviralci 11 -hsd1
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
ZA200703307B (en) Indol derivatives as inhibitors of soluble adenylyl cyclase
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
IL193981A0 (en) Novel heterocyclic nf-kb inhibitors
EP2102149A4 (en) STYLENE DERIVATIVES FOR ADP-RIBOSYLCYCLASE INHIBITORS
ZA200800153B (en) Inhibitors of soluble adenylate cyclase
DOP2007000058A (es) Inhibidores de la adenilato ciclasa soluble
HK1100943A1 (en) Inhibitors of glutaminyl cyclase
GB0622245D0 (en) Novel inhibitors of glutaminyl cyclase
GB0622244D0 (en) Novel inhibitors of glutaminyl cyclase
GB0622246D0 (en) Novel inhibitors of glutaminyl cyclase